• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Abbreviated MRI is superior to whole-breast ultrasound for detection of cancer in dense breasts

byNeel MistryandTeddy Guo
June 25, 2025
in Chronic Disease, Imaging and Intervention, Oncology
Reading Time: 2 mins read
3D mammography (tomosynthesis) enhances accuracy of breast cancer screening
Share on FacebookShare on Twitter

1. Abbreviated MRI detected three times as many invasive cancers compared with ABUS.

2. Contrast-enhanced mammography detected a greater number of invasive cancers compared to ABUS, although this was not statistically significant.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Women with dense breasts face barriers in breast cancer detection since standard mammograms are less effective for them. It is unclear which supplemental imaging method works best for the detection of breast malignancies in this group. This randomized controlled trial aimed to compare abbreviated MRI, automated breast ultrasound (ABUS), and contrast-enhanced mammography with standard mammography in detecting cancer among women with dense breasts. The primary outcome of this study was the rate of cancer detection, while the key secondary outcome was the recall and biopsy rates resulting from each supplemental imaging technique. According to study results, abbreviated MRI and contrast-enhanced mammography detected three times more invasive cancers than ABUS. Although this study was well done, it was limited by not addressing the potential for overdiagnosis associated with additional cancer detection.

Click to read the study in The Lancet

Relevant Reading: Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence

RELATED REPORTS

Daraxonrasib extends survival in metastatic pancreatic cancer

Historical redlining associated with lower breast cancer screening across urban neighborhoods

Molecularly guided therapy may improve outcomes in patients with unfavourable cancer of unknown primary compared with standard chemotherapy

In-depth [randomized controlled trial]: Between Oct 18, 2019, and Mar 30, 2024, 37,774 patients were screened for eligibility across 10 breast screening sites in the UK. Included were patients aged 50–70 with dense breasts and a negative screening mammogram who were invited to undergo supplemental imaging. Altogether, 6,305 patients (2,130 in abbreviated breast MRI, 2,141 in ABUS, and 2,034 in contrast-enhanced mammogram) were included in the final analysis. The primary outcome of cancer detection rate was highest for contrast-enhanced mammography (19.2 per 1000, 95% confidence interval [CI] 13.7-26.1) and abbreviated MRI (17.4 per 1000, 95% 12.2-23.9), both significantly higher than ABUS (4.2 per 1000, 95% 1.9-8.0). The detection rate for abbreviated MRI was significantly higher than for ABUS (p=0.047). Overall, findings from this study suggest that abbreviated MRI and contrast-enhanced mammography are more effective than ABUS at detecting breast cancer in women with dense breasts.

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: automated breast ultrasoundbreastBreast Cancerbreast cancer screeningbreast MRIcontrast-enhanced mammographymammogrammammographymrioncologyultrasoundwomen's health
Previous Post

Volumetric diet and time-restricted eating demonstrate similar outcomes for weight reduction

Next Post

Food compounds associated with disease activity in inflammatory bowel disease 

RelatedReports

Oncology

Daraxonrasib extends survival in metastatic pancreatic cancer

September 17, 2026
Oncology

Historical redlining associated with lower breast cancer screening across urban neighborhoods

September 13, 2026
Quick Take: Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening
Chronic Disease

Molecularly guided therapy may improve outcomes in patients with unfavourable cancer of unknown primary compared with standard chemotherapy

September 7, 2026
Long-term outcomes for off-pump and on-pump CABG are similar
Weekly Rewinds

2 Minute Medicine Rewind September 7, 2026

September 7, 2026
Next Post
Biosimilar to infliximab shows equivalent safety and efficacy for treating Crohn’s disease

Food compounds associated with disease activity in inflammatory bowel disease 

PCI not superior to medical therapy alone in stable coronary disease: The COURAGE study

Novel inhibitory antibody, MAR001, lowers triglycerides and remnant cholesterol in humans

Evaluating scar outcomes in pediatric burn patients following skin grafting 

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Daraxonrasib extends survival in metastatic pancreatic cancer
  • Artificial intelligence (AI) scribes showed mixed effects on documentation time and improvements in physician well-being
  • A lower threshold for referral to the emergency department for outpatient hyperkalemia may reduce mortality
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.